Cerebral venous thrombosis of the sphenoparietal sinus: A case report
Tóm tắt
Cerebral venous thrombosis (CVT) is a rare cause of stroke that preferentially affects reproductive aged females and patients with hereditary or acquired thrombotic risk factors. The superior sagittal sinus and transverse sinus are the two most common sites for thrombus formation.
We report a case of CVT arising in a very rare location, the sphenoparietal sinus. A 32-year-old woman with a history of factor V Leiden mutation and multiple prior episodes of venous thromboembolism presented with a new-onset seizure, headache, and emesis. CT angiography ultimately revealed thrombosis of the left sphenoparietal sinus. The patient received anticoagulation with apixaban with resolution of symptoms and without complications.
This case serves as an uncommon example of sphenoparietal sinus thrombosis managed with novel oral anticoagulant treatment.
Từ khóa
Tài liệu tham khảo
2019, A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate with Warfarin in Patients with Cerebral Venous and Dural Sinus;
Bousser, 2007, Cerebral venous thrombosis: An update, Lancet Neurol, 6, 162, 10.1016/S1474-4422(07)70029-7
Breschet, 1829, Research of the Anatomy, Physiology, and Pathology of the Venus System with Special Emphasis on the Veins of Bones
Bushnell, 2014, Evaluation and management of cerebral venous thrombosis, Continuum (Minneap Minn), 20, 335
Coutinho, 2014, Declining mortality in cerebral venous thrombosis: A systematic review, Stroke, 45, 1338, 10.1161/STROKEAHA.113.004666
di Caprera, 2018, Cerebral venous thrombosis presenting like a subdural hemorrhage at magnetic resonance imaging: An Italian case report, Eur J Radiol Open, 5, 31, 10.1016/j.ejro.2017.12.001
Dmytriw, 2018, Cerebral venous thrombosis: State of the art diagnosis and management, Neuroradiology, 60, 669, 10.1007/s00234-018-2032-2
Ferro, 2019, Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: A randomized clinical trial, JAMA Neurol, 76, 1457, 10.1001/jamaneurol.2019.2764
Lee, 2020, Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis, J Thromb Thrombolysis, 50, 724, 10.1007/s11239-020-02106-7
Patel, 2015, Cerebral venous thrombosis: Current and newer anticoagulant treatment options, Neurologist, 20, 80, 10.1097/NRL.0000000000000049
Ruíz, 2004, The sphenoparietal sinus of breschet: Does it exist? An anatomic study, AJNR Am J Neuroradiol, 25, 112
Sader, 2018, Management of venous sinus thrombosis, Neurosurg Clin N Am, 29, 585, 10.1016/j.nec.2018.06.011
Saposnik, 2011, Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American heart association/ American stroke association, Stroke, 42, 1158, 10.1161/STR.0b013e31820a8364
Silvis, 2016, Risk factors for cerebral venous thrombosis, Semin Thromb Hemost, 42, 622, 10.1055/s-0036-1584132
2019, Study of Rivaroxaban for CeREbral Venous Thrombosis
Tubbs, 2007, The sphenoparietal sinus, Neurosurgery, 60, ONS9